Cargando…
Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders
Mental illnesses are a global health challenge, and effective medicines are needed to treat these conditions. Psychotropic drugs are commonly prescribed to manage mental disorders, such as schizophrenia, but unfortunately, they can cause significant and undesirable side effects, such as myocarditis,...
Autores principales: | Mlambo, Ronald, Liu, Jia, Wang, Qian, Tan, Songwen, Chen, Chuanpin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142280/ https://www.ncbi.nlm.nih.gov/pubmed/37111360 http://dx.doi.org/10.3390/ph16040603 |
Ejemplares similares
-
Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial
por: Stabell, L.A, et al.
Publicado: (2023) -
Aripiprazole for olanzapine-induced symptomatic hyper prolactinemia
por: Aggarwal, Ashish, et al.
Publicado: (2010) -
Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022) -
Augmentation of Clozapine with Aripiprazole in Severe Psychotic Bipolar and Schizoaffective Disorders: A Pilot Study
por: Benedetti, Alessandra, et al.
Publicado: (2010) -
Comparison of Mental Health Resources Used by Patients With Bipolar Disorder Treated With Risperidone, Olanzapine, or Quetiapine
por: Gianfrancesco, Frank, et al.
Publicado: (2005)